Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
15
ARWR Quote, Financials, Valuation and Earnings
Last price:
$19.46
Seasonality move
:
23.49%
Day range:
$19.18 - $20.21
52-week range:
$17.05 - $39.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.83x
P/B ratio:
13.06x
Volume:
3.9M
Avg. volume:
1.9M
1-year change:
-30.06%
Market cap:
$2.4B
Revenue:
$3.6M
EPS (TTM):
-$5.01
ARWR Analysts' Consensus Rating
The 12 analysts providing 12-month price projections for Arrowhead Pharmaceuticals shares anticipate an average target of $47.43, ranging from a low estimate of $23.00 to a high estimate of $80.00. This average target implies a growth of 143.66% compared to the current stock price of $19.47.
Consensus Price Target
$47.43
Highest Price Target
$80.00
Lowest Price Target
$23.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 7 | 7 | 7 |
| Hold | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ARWR Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
